News Releases
The latest company news, press releases, and resources about Servier and everything our company has to offer.
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
11.03.2025Servier Announces Positive Findings from Longer-Term Analysis of the Phase 3 INDIGO Trial Showing Continued Durable Treatment Effect of VORANIGO® (vorasidenib) Published in The Lancet Oncology-
10.31.2025Servier's VORANIGO® (vorasidenib) Receives Prestigious 2025 Prix Galien USA Award
-
09.22.2025European Commission Approves Servier's VORANIGO® (vorasidenib) as the First Targeted Therapy for Grade 2 IDH-Mutant Glioma in the EU
-
09.08.2025Servier acquires potential treatment for Fragile X syndrome, the most common genetic cause of autism spectrum disorder
-
09.02.2025Servier and IDEAYA Biosciences Partner to Bring Darovasertib, a Promising Uveal Melanoma Treatment, to Patients Worldwide
Media Contacts
Servier Media Relations
us2mediarelations@servier.com